Table 1.
Donor characteristics and collection regimens.
| Apheresis group (n = 10) | Non-stimulated control group (n = 10) | ||
|---|---|---|---|
| Sex (M:F) | M:5 F:5 | M:5 F:5 | |
| Age, median year (range) | 42 (23–58) | 42 (21–61) | |
| GC final volume (ml) | 350 | – | |
| Pred | G-CSF | ||
| Leukapheresis duration, min (range) | 96 (64–138) | 80 (66–104) | – |
| Dose | 50 mg (per os) | 300 mcg (intravenous) | – |
| Time before apheresis | 12 to 18 h | 24 h | – |
| Inclusion criteria Age 18–60 Men and women |
|||
| Exclusion criteria Infectious diseases transmitted by blood (hepatitis B and C, syphilis, HIV 1 and 2 and HTLV I/I) Complications during apheresis procedure Recent infections that required treatments (antibiotics, antifungals) |
|||